# EDGAR Filing Document

**Accession Number:** 0001512848
**File Stem:** 0000897069-25-001415
**Filing Date:** 2025-9
**Character Count:** 34848
**Document Hash:** e64cf776337b485ab2587e798e7f1bc5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000897069-25-001415.hdr.sgml**: 20250903

**ACCESSION NUMBER**: 0000897069-25-001415

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250903

**EFFECTIVENESS DATE**: 20250903

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEA Management Company, LLC
- **CENTRAL INDEX KEY:** 0001512848

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-14302
- **FILM NUMBER:** 251286755

**BUSINESS ADDRESS:**
- **STREET 1:** 1954 GREENSPRING DRIVE
- **STREET 2:** SUITE 600
- **CITY:** TIMONIUM
- **STATE:** MD
- **ZIP:** 21093
- **BUSINESS PHONE:** 410-842-4000

**MAIL ADDRESS:**
- **STREET 1:** 1954 GREENSPRING DRIVE
- **STREET 2:** SUITE 600
- **CITY:** TIMONIUM
- **STATE:** MD
- **ZIP:** 21093

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001512848

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** NEA Management Company, LLC

**Address:** 1954 GREENSPRING DRIVE, TIMONIUM, MD 21093

**Telephone number:** 410-842-4000

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-14302

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Adaptimmune Therapeutics      | 00653A107 | 05/29/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2024.                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |       17082615 |                0 | FOR         |                                 17082615 | FOR                         |  |
| Adaptimmune Therapeutics      | 00653A107 | 05/29/2025     | To approve, on a non-binding, advisory basis, the preferred frequency of future shareholder advisory votes on the compensation of the Company's named executive officers. (Advisory Resolution)                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |       17082615 |                0 | 1 Year      |                                 17082615 | FOR                         |  |
| Arcellx, Inc.                 | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        3748039 |                0 | FOR         |                                  3748039 | FOR                         |  |
| Aurinia Pharmaceuticals Inc.  | 05156V102 | 05/15/2025     | To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular.                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        3969834 |                0 | FOR         |                                  3969834 | FOR                         |  |
| Celcuity Inc.                 | 15102K100 | 05/13/2025     | To approve, by a non-binding and advisory vote, compensation of the named executive officers.                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1250001 |                0 | FOR         |                                  1250001 | FOR                         |  |
| Champions Oncology, Inc.      | 15870P307 | 10/14/2024     | Proposal to approve the non-binding advisory resolution relating to the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        1713720 |                0 | FOR         |                                  1713720 | FOR                         |  |
| Coursera, Inc.                | 22266M104 | 05/20/2025     | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |       12867769 |                0 | FOR         |                                 12867769 | FOR                         |  |
| Crispr Therapeutics AG        | H17182108 | 06/05/2025     | Binding vote on maximum non-performance-related compensation for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        1590002 |                0 | FOR         |                                  1590002 | FOR                         |  |
| Crispr Therapeutics AG        | H17182108 | 06/05/2025     | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026.                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        1590002 |                0 | FOR         |                                  1590002 | FOR                         |  |
| Crispr Therapeutics AG        | H17182108 | 06/05/2025     | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025.                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        1590002 |                0 | FOR         |                                  1590002 | FOR                         |  |
| Crispr Therapeutics AG        | H17182108 | 06/05/2025     | Non-binding advisory vote on the compensation paid to the Company's namedexecutive offi cers under U.S. securities law requirements.                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1590002 |                0 | FOR         |                                  1590002 | FOR                         |  |
| Desktop Metal, Inc.           | 25058X303 | 06/07/2024     | To approve, on a non-binding advisory basis, the executive officer compensation that will or may be paid to Desktop Metal's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement.                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1440758 |                0 | FOR         |                                  1440758 | FOR                         |  |
| Gossamer Bio, Inc.            | 38341P102 | 06/25/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |       18093034 |                0 | FOR         |                                 18093034 | FOR                         |  |
| Gossamer Bio, Inc.            | 38341P102 | 06/25/2025     | Approval of the amendment and restatement of the Company's 2019 Incentive Award Plan.                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |       18093034 |                0 | FOR         |                                 18093034 | FOR                         |  |
| Inventiva SA                  | 46124U107 | 05/22/2025     | Final approval of the fixed and variable compensation paid or awarded to Mr. MarkPruzanski in his capacity as Chairman of the Board of Directors for the financial year ended December 31, 2024 (from December 13, 2024).                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        8350730 |                0 | FOR         |                                  8350730 | FOR                         |  |
| Inventiva SA                  | 46124U107 | 05/22/2025     | Final approval of the fixed and variable compensation paid or awarded to Mr.Frédéric Cren in his capacity as Chairman of the Board of Directors and Chief Executive Officer until December 13, 2024 and as Chief Executive Officer fromDecember 13, 2024 for the financial year ended December 31, 2024.                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |        8350730 |                0 | FOR         |                                  8350730 | FOR                         |  |
| Inventiva SA                  | 46124U107 | 05/22/2025     | Final approval of the fixed and variable compensation paid or awarded to Mr. Pierre Broqua in his capacity as Deputy Chief Executive Officer for the financialyear ended December 31, 2024.                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        8350730 |                0 | FOR         |                                  8350730 | FOR                         |  |
| Inventiva SA                  | 46124U107 | 05/22/2025     | Total compensation paid to members of the Board of Directors.                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        8350730 |                0 | FOR         |                                  8350730 | FOR                         |  |
| Inventiva SA                  | 46124U107 | 12/11/2024     | Approval of the compensati on policy for the Chief Executi ve Offi cer (applicati onfrom the date of separati on of functi ons).                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        6478126 |                0 | ABSTAIN     |                                  6478126 | AGAINST                     |  |
| Inventiva SA                  | 46124U107 | 12/11/2024     | Approval of the compensati on policy of the Chairperson of the Board of Directors(applicati on from the date of separati on of functi ons).                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        6478126 |                0 | FOR         |                                  6478126 | FOR                         |  |
| Inventiva SA                  | 46124U107 | 12/11/2024     | Authorization to the Board of Directors to grant free shares to employees and/orcertain corporate offi cers.                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        6478126 |                0 | FOR         |                                  6478126 | FOR                         |  |
| Inventiva SA                  | 46124U107 | 12/11/2024     | Amendment of the Deputy Chief Executive Officer's compensation policy.                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        6478126 |                0 | FOR         |                                  6478126 | FOR                         |  |
| Korro Bio, Inc.               | 500946108 | 06/11/2025     | Non-Binding Advisory Vote on the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        1092130 |                0 | 1 Year      |                                  1092130 | FOR                         |  |
| Korro Bio, Inc.               | 500946108 | 06/11/2025     | Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        1092130 |                0 | FOR         |                                  1092130 | FOR                         |  |
| Marker Therapeutics, Inc.     | 57055L206 | 06/06/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1625678 |                0 | FOR         |                                  1625678 | FOR                         |  |
| NeueHealth, Inc               | 10920V404 | 05/07/2025     | To approve, by non-binding, advisory vote, certain compensation arrangements for the Company's named executive officers in connection with the Merger.                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        3065348 |                0 | FOR         |                                  3065348 | FOR                         |  |
| NeueHealth, Inc               | 10920V404 | 05/29/2025     | To approve on a non-binding advisory basis the compensation of our named executive officers for 2024.                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        2727648 |                0 | FOR         |                                  2727648 | FOR                         |  |
| Phathom Pharmaceuticals, Inc. | 71722W107 | 06/03/2025     | To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency").                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        1960169 |                0 | 1 Year      |                                  1960169 | FOR                         |  |
| Phathom Pharmaceuticals, Inc. | 71722W107 | 06/03/2025     | To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay").                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        1960169 |                0 | FOR         |                                  1960169 | FOR                         |  |
| Reneo Pharmaceuticals, Inc.   | 75974E103 | 09/26/2024     | To consider and vote upon a proposal to approve the 2024 Equity Incentive Plan of NewCo.                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |        4786921 |                0 | FOR         |                                  4786921 | FOR                         |  |
| Rhythm Pharmaceuticals, Inc.  | 76243J105 | 06/24/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        2911349 |                0 | FOR         |                                  2911349 | FOR                         |  |
| Rhythm Pharmaceuticals, Inc.  | 76243J105 | 09/18/2024     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        2909956 |                0 | FOR         |                                  2909956 | FOR                         |  |
| Rhythm Pharmaceuticals, Inc.  | 76243J105 | 09/18/2024     | Reapproval of the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        2909956 |                0 | FOR         |                                  2909956 | FOR                         |  |
| Savara Inc.                   | 805111101 | 06/05/2025     | To approve, on an advisory basis, the compensation of our named executives.                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |       24471264 |                0 | FOR         |                                 24471264 | FOR                         |  |
| Savara Inc.                   | 805111101 | 06/05/2025     | To indicate, on an advisory basis, the preferred frequency of holding an advisory vote on the compensation of our named executives.                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |       24471264 |                0 | 1 Year      |                                 24471264 | FOR                         |  |
| Synlogic, Inc.                | 87166L209 | 12/04/2024     | To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        2922803 |                0 | FOR         |                                  2922803 | FOR                         |  |
| Trevi Therapeutics Inc        | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        9434612 |                0 | FOR         |                                  9434612 | FOR                         |  |
| Trevi Therapeutics Inc        | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        9434612 |                0 | 1 Year      |                                  9434612 | FOR                         |  |
| Trevi Therapeutics Inc        | 89532M101 | 06/11/2025     | Approval of an amendment to the Trevi Therapeutics, Inc. 2019 Stock Incentive Plan to increase the number of shares available for issuance under the plan by 6,000,000 shares of common stock, and make certain other amendments.                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        9434612 |                0 | FOR         |                                  9434612 | FOR                         |  |
| Verona Pharma PLC             | 925050106 | 04/24/2025     | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        2688566 |                0 | FOR         |                                  2688566 | FOR                         |  |
| Wheels Up Experience Inc.     | 96328L205 | 06/10/2025     | To approve an amendment to the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as previously amended by Amendment No. 1 thereto, the "Amended and Restated 2021 LTIP"), to increase the aggregate number of shares of the Company's Class A common stock, $0.0001 par value per share ("Common Stock"), available for awards made under the Amended and Restated 2021 LTIP and extend the termination date of such plan to March 26, 2035. | SECTION 14A SAY-ON-PAY VOTES |         106125 |                0 | FOR         |                                   106125 | FOR                         |  |
| Wheels Up Experience Inc.     | 96328L205 | 06/10/2025     | To approve the non-binding, advisory vote to approve named executive officer compensation for the fiscal year ended December 31, 2024.                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         106125 |                0 | FOR         |                                   106125 | FOR                         |  |
| Wheels Up Experience Inc.     | 96328L205 | 06/10/2025     | To approve the Wheels Up Experience Inc. Performance Award Agreement, dated as of May 20, 2024, granted to David Harvey, the Company's Chief Commercial Officer, and authorize the Company to issue up to 15,000,000 shares of Common Stock thereunder, subject to the satisfaction of the applicable vesting conditions under such plan, if at all.                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         106125 |                0 | FOR         |                                   106125 | FOR                         |  |
| Wheels Up Experience Inc.     | 96328L205 | 06/10/2025     | To approve the Wheels Up Experience Inc. Performance Award Agreement, dated as of March 31, 2025, granted to John Verkamp, the Company's Chief Financial Officer, and authorize the Company to issue up to 12,000,000 shares of Common Stock thereunder, subject to the satisfaction of the applicable vesting conditions under such plan, if at all.                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         106125 |                0 | FOR         |                                   106125 | FOR                         |  |
| X4 Pharmaceuticals, Inc.      | 98420X103 | 06/09/2025     | To hold a non-binding, advisory "say-on-pay" vote on the Company's executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |       14986793 |                0 | FOR         |                                 14986793 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** NEA Management Company, LLC

**By (Signature):** Stephanie Brecher

**By (Printed Signature):** Stephanie Brecher

**By (Title):** Chief Legal Officer

**Date:** 09/02/2025